Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Sigmoidal Tumour × Levobupivacaine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Sigmoidal Tumour 1 Pain, Postoperative 1

Interventions

Morphine 1 Levobupivacaine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01825993 2013-04-08

2013/004

Corporacion Parc Tauli

Phase 3 Unknown

Sigmoidal Tumour

Data powered by HemOnc (CC BY 4.0) Colophon ⚡